Understanding “Hybrid Immunity”: Comparison and Predictors of Humoral Immune Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Infection (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) VaccinesNusrat J Epsi, Sharon W Chi, Carlos J Maldonado et al.|Clinical Infectious Diseases|2022Cited by 59
Durability of SARS-CoV-2–Specific T-Cell Responses at 12 Months PostinfectionZhongyan Lu, Daniel E. Clark, Eric D. Laing et al.|The Journal of Infectious Diseases|2021Cited by 42
COVID-19 Outcomes Among US Military Health System Beneficiaries Include Complications Across Multiple Organ Systems and Substantial Functional ImpairmentStephanie A Richard, Simon Pollett, Charlotte Lanteri et al.|Open Forum Infectious Diseases|2021Cited by 32
Clinical, Immunological, and Virological SARS-CoV-2 Phenotypes in Obese and Nonobese Military Health System BeneficiariesNusrat J Epsi, S. Bertrán de Lis, Stephanie A Richard et al.|The Journal of Infectious Diseases|2021Cited by 18
COVID-19 Patient-Reported Symptoms Using FLU-PRO Plus in a Cohort Study: Associations With Infecting Genotype, Vaccine History, and Return to HealthStephanie A Richard, Josh Chenoweth, Nusrat J Epsi et al.|Open Forum Infectious Diseases|2022Cited by 14